Nanostructured Lipid Carriers-Containing Anticancer Compounds: Preparation, Characterization, and Cytotoxicity Studies
Maria Luisa Bondı̀(Institute of Nanostructured Materials), Girolamo Cirrincione(University of Palermo), Annamaria Martorana(University of Palermo), Emanuela Fabiola Craparo(University of Palermo), Patrizia Diana(University of Palermo), Melchiorre Cervello(Foundation for Biomedical Research), Gaetano Giammona(University of Palermo), Antonina Azzolina(Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy)
Cited by 72
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
1,2,3‐Triazole in Heterocyclic Compounds, Endowed with Biological Activity, through 1,3‐Dipolar Cycloadditions
|European Journal of Organic Chemistry|2014|341
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance
|Cell Death and Disease|2016|141
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
|Journal of Medicinal Chemistry|2022|139
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
|Journal of Hematology & Oncology|2025|128